This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The General Hospital Corporation. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Denis Titov: Innovator in Mitochondrial Disease Treatment
Introduction
Denis Titov is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of mitochondrial diseases through his innovative research and inventions. His work focuses on developing solutions for conditions associated with mitochondrial dysfunction.
Latest Patents
Denis Titov holds a patent for "Protein prostheses for mitochondrial diseases or conditions." This invention encompasses water-forming NADH and NADPH oxidases, which are utilized to treat various mammalian diseases or conditions linked to an elevated NADH/NAD+ ratio or NADPH/NADP+ ratio. The patent addresses pathologies such as disorders caused by defects in the mitochondrial respiratory chain, glucose metabolism disorders, cancers associated with reductive stress, and aging. Additionally, this invention serves as a research tool for investigating the effects of exogenous water-forming NADH or NADPH oxidases on mammalian cell metabolism, including human cells.
Career Highlights
Denis Titov is affiliated with The General Hospital Corporation, where he continues to advance his research in mitochondrial diseases. His work has garnered attention for its potential to improve treatment options for patients suffering from these complex conditions.
Collaborations
Denis collaborates with esteemed colleagues, including Vamsi K Mootha and Valentin Cracan. Their combined expertise enhances the research efforts aimed at understanding and treating mitochondrial disorders.
Conclusion
Denis Titov's innovative contributions to the field of mitochondrial disease treatment highlight the importance of research and invention in addressing complex health challenges. His patent and ongoing work promise to pave the way for new therapeutic approaches in the future.